Page last updated: 2024-08-26

u 74006f and Craniocerebral Injuries

u 74006f has been researched along with Craniocerebral Injuries in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleishaker, JC; Hulst, LK; Peters, GR1
Andrus, PK; Hall, ED; Yonkers, PA1
Marshall, LF; Marshall, SB1
Cross, CJ; Fleishaker, JC; Straw, RN1
Bricolo, A; Fearnside, M; Iannotti, F; Klauber, MR; Lagarrigue, J; Lobato, R; Maas, AI; Marshall, LF; Marshall, SB; Means, ED; Morris, GF; Musch, B; Persson, L; Pickard, JD; Piek, J; Servadei, F; Wellis, GN1
Ayer, DE; Belonga, KL; Braughler, JM; Hall, ED; Houser, DJ; Jacobsen, EJ; Krook, MA; McCall, JM; Palmer, JR; Van Doornik, FJ1

Trials

1 trial(s) available for u 74006f and Craniocerebral Injuries

ArticleYear
A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.
    Journal of neurosurgery, 1998, Volume: 89, Issue:4

    Topics: Adult; Brain Injuries; Cohort Studies; Craniocerebral Trauma; Female; Follow-Up Studies; Glasgow Coma Scale; Hematoma, Epidural, Cranial; Humans; Hypotension; Hypoxia; Male; Neuroprotective Agents; Placebos; Pregnatrienes; Prognosis; Prospective Studies; Risk Factors; Sex Factors; Subarachnoid Hemorrhage; Survival Rate; Treatment Outcome

1998

Other Studies

5 other study(ies) available for u 74006f and Craniocerebral Injuries

ArticleYear
Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:5

    Topics: Adult; Chromatography, High Pressure Liquid; Craniocerebral Trauma; Drug Tolerance; Half-Life; Humans; Infusions, Intravenous; Lipid Peroxides; Male; Middle Aged; Pregnatrienes; Subarachnoid Hemorrhage

1994
Brain hydroxyl radical generation in acute experimental head injury.
    Journal of neurochemistry, 1993, Volume: 60, Issue:2

    Topics: Acute Disease; Animals; Antioxidants; Brain; Craniocerebral Trauma; Free Radicals; Gentisates; Hydroxides; Hydroxybenzoates; Hydroxyl Radical; Male; Mice; Mice, Inbred Strains; Pregnatrienes; Prosencephalon; Time Factors

1993
Pitfalls and advances from the international tirilazad trial in moderate and severe head injury.
    Journal of neurotrauma, 1995, Volume: 12, Issue:5

    Topics: Animals; Antioxidants; Clinical Trials as Topic; Craniocerebral Trauma; Female; Humans; Male; Multicenter Studies as Topic; Pregnatrienes; Radiography; Risk Assessment; Treatment Outcome

1995
Pharmacokinetics of tirilazad and U-89678, an active, reduced metabolite, following acute head trauma in adults.
    Journal of pharmaceutical sciences, 1997, Volume: 86, Issue:4

    Topics: Adult; Area Under Curve; Craniocerebral Trauma; Female; Humans; Male; Neuroprotective Agents; Pregnatrienes

1997
Novel 21-aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:4

    Topics: Amines; Animals; Antioxidants; Craniocerebral Trauma; Drug Evaluation, Preclinical; Lipid Peroxidation; Male; Mice; Pregnatrienes; Rats; Spinal Injuries; Steroids; Structure-Activity Relationship

1990